(ARDT) Ardent Health Partners - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US03980N1072

ARDT: Hospitals, Clinics, Medical Services, Telehealth, Ambulatory Care, Emergency Services, Diagnostic Imaging

Ardent Health Partners, Inc. (NYSE:ARDT) operates a diverse network of healthcare facilities across the United States, delivering comprehensive medical services through its hospitals, clinics, and telehealth platforms. The company provides a broad spectrum of care, including general and specialty services such as cardiology, oncology, orthopedics, and womens health, across both inpatient and ambulatory settings. Its ambulatory network encompasses primary and specialty care clinics, ambulatory surgery centers, urgent care facilities, free-standing emergency departments, and diagnostic imaging centers. Ardent also manages acute care hospitals, rehabilitation centers, and surgical hospitals, ensuring a continuum of care for patients. Founded in 2001 and headquartered in Brentwood, Tennessee, the company is a subsidiary of EGI-AM Investments, L.L.C., and is recognized for its commitment to quality patient outcomes and operational efficiency.

Based on current and , Ardent Health Partners, Inc. is expected to maintain a stable operational trajectory over the next three months. Technically, the stock is trading near its SMA 20 (12.39) and slightly below its SMA 50 (13.45), indicating a potential consolidation phase. The ATR of 0.59 suggests moderate volatility, with price movements likely confined within a narrow range. Fundamentally, the forward P/E of 9.55 signals investor expectations of improved earnings, while the current P/S ratio of 0.46 reflects undervaluation relative to its revenue. Overall, ARDT is positioned for cautious optimism, with potential upside driven by its strategic focus on cost management and service expansion.

Additional Sources for ARDT Stock

ARDT Stock Overview

Market Cap in USD 2,591m
Sector Healthcare
Industry Medical Care Facilities
GiC Sub-Industry Health Care Facilities
IPO / Inception 2024-07-18

ARDT Stock Ratings

Growth Rating -49.7
Fundamental 57.3
Dividend Rating 0.0
Rel. Strength -17.8
Analysts 4.4/5
Fair Price Momentum 11.05 USD
Fair Price DCF 19.26 USD

ARDT Dividends

No Dividends Paid

ARDT Growth Ratios

Growth Correlation 3m -89.2%
Growth Correlation 12m -82.4%
Growth Correlation 5y -82.4%
CAGR 5y -21.23%
CAGR/Max DD 5y -0.50
Sharpe Ratio 12m -0.09
Alpha -26.68
Beta 0.212
Volatility 53.98%
Current Volume 143.7k
Average Volume 20d 317.2k
What is the price of ARDT stocks?
As of April 30, 2025, the stock is trading at USD 12.65 with a total of 143,664 shares traded.
Over the past week, the price has changed by +7.11%, over one month by -8.00%, over three months by -13.95% and over the past year by -21.23%.
Is Ardent Health Partners a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Ardent Health Partners (NYSE:ARDT) is currently (April 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 57.28 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ARDT as of April 2025 is 11.05. This means that ARDT is currently overvalued and has a potential downside of -12.65%.
Is ARDT a buy, sell or hold?
Ardent Health Partners has received a consensus analysts rating of 4.40. Therefor, it is recommend to buy ARDT.
  • Strong Buy: 6
  • Buy: 2
  • Hold: 2
  • Sell: 0
  • Strong Sell: 0
What are the forecast for ARDT stock price target?
According to ValueRays Forecast Model, ARDT Ardent Health Partners will be worth about 11.9 in April 2026. The stock is currently trading at 12.65. This means that the stock has a potential downside of -5.69%.
Issuer Forecast Upside
Wallstreet Target Price 22.8 80.1%
Analysts Target Price 22.8 80.1%
ValueRay Target Price 11.9 -5.7%